æ±äº¬å€§åŠ(æ±å€§)ãšã«ã«ããã¯ã¯5æ21æ¥ã120Lã®ã¢ã¯ãªã«ããã¯ã¹äžã«ãšã¢ããŸã«åããæ°åã³ãããŠã€ã«ã¹(SARS-CoV-2)ãåŽé§ããç©ºæ°æž æµæ©ã«æèŒããå è§Šåªã«405nmã®å¯èŠå ã20åéç §å°ãããšãããSARS-CoV-2ã99.9ïŒ äžæŽ»åã§ããããšãå®èšŒãããšçºè¡šããããŸããå è§Šåªã«å±èµ·å ã120åç §å°ãããšãããæ¶²äœäžã®SARS-CoV-2ã®æææ§ãæ€åºéç以äžãšãªãããšã確èªãããããšãåãããŠçºè¡šãããã
åææã¯ãæ±å€§å€§åŠé¢ 蟲åŠçåœç§åŠç ç©¶ç§ èŸ²åŠåœéå°æ»ã®æŸæµŠéŒä»ç¹ä»»å©æãåã»Chieh-Wen Lo倧åŠé¢çãçååŠç ç©¶æ(çç ) å éåå·¥åŠç ç©¶ã»ã³ã¿ãŒ å éåå¶åŸ¡æè¡éçºããŒã ã®åç°æºä¹ããŒã ãªãŒããŒãã«ã«ããã¯ã®æäºæœ€äž 代衚åç· åœ¹ç€Ÿé·ãåã»èœåå¹³å «éåºå ±éšéšé·ãçç å éåå·¥åŠç ç©¶ã»ã³ã¿ãŒ å éåå¶åŸ¡æè¡éçºããŒã ã®æäžæŠæŽç ç©¶å¡ãåã»æè€åŸ³äººäžçŽç ç©¶å¡ãåã»å°å·è²Žä»£ç ç©¶å¡ãåã»ç¥ææ·³åž 客å¡äž»ç®¡ç ç©¶å¡ãçç ã€ãããŒã·ã§ã³æšé²ã»ã³ã¿ãŒ 蟚éç¹å¥ç 究宀ã®èŸšé矩巳 ç¹å¥æèç ç©¶å¡(ç ç©¶åœæ)ãæ¥æ¬å€§åŠ(æ¥å€§) å»åŠéšå ç§åŠç³» è¡æ¶²è åç å ç§åŠåéã®äžå·åªå©æãæ¥å€§å»åŠéšå ç§åŠç³» è¡æ¶²è åç å ç§åŠåé/æ¥å€§ ç·åç§åŠç ç©¶æã®æŠäºæ£çŸææãæ±å€§å€§åŠé¢ 蟲åŠçåœç§åŠç ç©¶ç§ èŸ²åŠåœéå°æ»ã®ééœåç¹ä»»ææãã®å ±åç ç©¶ããŒã ã«ãããã®ã詳现ã¯ããŠã€ã«ã¹ã顿ãšãããªãŒãã³ã¢ã¯ã»ã¹ãžã£ãŒãã«ãVirusesãã«æ²èŒãããã
æ°åã³ãããŠã€ã«ã¹(SARS-CoV-2)ã¯ããããä»çããç©äœã®è¡šé¢ãã飿²«ãªã©ã®ãšã¢ããŸã«ãä»ããŠææããããšãããã£ãŠãããæææ¡å€§ãé²ãããã«ã¯ã人ã ãéãŸããããªå±å ã®å ¬å ±æœèšãªã©ãç°å¢ãã®ãã®ããSARS-CoV-2ãé€å»ããããšãæ±ããããŠããã
å è¡ç ç©¶ã«ããæ¬¡äºå¡©çŽ é žãªã©ã®ååŠç©è³ªã玫å€ç·ããSARS-CoV-2ãäžæŽ»åããããšãããã£ãŠãããã人äœãžã®æå®³æ§ã®åé¡ãªã©ãããããã人ã ãæ¥åžžçæŽ»ãè¡ã£ãŠããå Žã§ã®äœ¿çšã«ã¯é©ããŠããªãããã®ãããçæŽ»ç°å¢ã«ãããŠäººäœã«å®³ãäžããããšãªããå¹ççã«ãŠã€ã«ã¹ãäžæŽ»åã§ããæ°ããªæ¹æ³ã®éçºãæ±ããããŠããã
ããã§æåŸ ãããŠããã®ãããé žåãã¿ã³ããªã©ã«ä»£è¡šãããå è§Šåªã ãæè¿ãããã®è©³çްãªã¡ã«ããºã ã¯ãŸã è§£æãããŠããªããã玫å€ç·ãçšããé žåãã¿ã³å è§Šåªã«ãããæ¶²äœäžã®SARS-CoV-2ã®äžæŽ»åèœãå ±åãããŠããã
玫å€ç·ã§ã¯ãªãå¯èŠå ç·ãå©çšã§ããããšããã¹ãã§ããããå¯èŠå ç·ãå©çšããé žåãã¿ã³å è§Šåªãæ¶²äœäžã®SARS-CoV-2ãäžæŽ»åã§ãããåŠããããã«ç°å¢äžã§ã®SARS-CoV-2ã®ææçµè·¯ãšããŠéèŠãªãšã¢ããŸã«äžã§ã®å¹æãªã©ã«ã€ããŠã¯ããŸã æããã«ãªã£ãŠããªãã£ãã
-

å è§Šåªã«ããSARS-CoV-2ã®äžæŽ»åã®æŠç¥å³ã(1)ææåãæããSARS-CoV-2ã®å¹é€æ¶²ãå è§Šåªãå¡åžããã·ãŒãã«ä¹ãããã405nmã®å¯èŠå ã§å è§Šåªãå±èµ·ãããã(2)ãšã¢ããŸã«äžã®SARS-CoV-2ã®äžæŽ»å詊éšã§ã¯ãææåãæããSARS-CoV-2ããšã¢ããŸã«ãšããŠåŽé§ãããå è§ŠåªãæèŒããç©ºæ°æž æµæ©ã§åŠçãããã(3)ãã®çµæããšã¢ããŸã«äžã®ãŠã€ã«ã¹ã¯20åéã®å è§ŠåªåŠçã§99.9ïŒ äžæŽ»åãããã(4)ãŸããå è§Šåªã§åŠçããSARS-CoV-2ãšæªåŠçã®SARS-CoV-2ã®åœ¢æ ãé»åé¡åŸ®é¡ãçšããŠèгå¯ãè¡ããããä»åã®è©Šéšã®çµæã405nmã®å¯èŠå ã§å±èµ·ããå è§Šåªåå¿ã«ããSARS-CoV-2ã®ãŠã€ã«ã¹ç²åãžã®æå·ãRNAã®æå·ããŠã€ã«ã¹ã¿ã³ãã¯è³ªã®åè§£ãªã©ã確èªããããããã®åå¿ãéããŠãSARS-CoV-2ãå è§Šåªåå¿ã«ãã£ãŠäžæŽ»åãããããšãæãããšãªã£ã (åºæ:æ±äº¬å€§åŠWebãµã€ã)
ããã§ç ç©¶ããŒã ã¯ä»åã120L(40cmÃ50cmÃ60cm)ã®ã¢ã¯ãªã«ããã¯ã¹äžã«å³ãšåçã®ãµã€ãº(ç²ååŸ5ÎŒm)ã®ãšã¢ããŸã«åããSARS-CoV-2ãåŽé§ããã¢ã¯ãªã«ããã¯ã¹äžã«é žåãã¿ã³å è§ŠåªãæèŒããç©ºæ°æž æµæ©ãã»ãããããã®å¹æã確èªããããã®å®éšã宿œããã®çµæããšã¢ããŸã«äžã®SARS-CoV-2ãã20åéã§99.9ïŒ äžæŽ»åã§ããããšãæãããšãªã£ããšããã
-

å è§Šåªã«ãããšã¢ããŸã«äžã®SARS-CoV-2ã®äžæŽ»åãå¹é€æ¶²äžã®SARS-CoV-2ããããã©ã€ã¶ãŒã«ãããšã¢ããŸããšããŠ120Lã®ã¢ã¯ãªã«ããã¯ã¹äžãžåŽé§ãè¡ãããå è§ŠåªãæèŒããç©ºæ°æž æµæ©ã«ãã20åéã®åŠçãè¡ããã((1)ïœ(3))ããã®ã®ã¡ã«ãšã¢ãµã³ãã©ãŒã«ãã£ãŠååããããŠã€ã«ã¹ææäŸ¡ã枬å®ãããããã®çµæãå è§Šåªã«405nmã®å ãç §å°ããå è§Šåªåå¿ãå±èµ·ããããµã³ãã«ã«ãããŠãæéäŸåçã«ææã«æææ§ãæžå°ããããšã確èªããã((4)ã»(5))ããŸãã405nmã®å ã®ã¿ãããšã¢ããŸã«äžã®SARS-CoV-2ã«å¯ŸããäžæŽ»åèœãæããããšã確èªãããããå è§Šåªã®æ¹ãäžæŽ»åèœã¯é«ãããšãæãããšãªã£ããäžæ¹ã§ãæªåŠçã®ã³ã³ãããŒã«çŸ€ã§ã¯ã20ååŸã§ãæææ§ãç¶æãããŠãããååãããSARS-CoV-2ã®ãŠã€ã«ã¹RNAéã®æž¬å®ã宿œãããçµæããŠã€ã«ã¹RNAã¯æéäŸåçã«æžå°ãããã®æžå°ã¯ãŠã€ã«ã¹ã®å䟡ãšã®é«ãçžé¢ã瀺ããããšãã((6)ã»(7)) (åºæ:æ±äº¬å€§åŠWebãµã€ã)
ãŸãã3cmè§ã®å è§Šåªãã³ãŒãã£ã³ã°ããã¬ã©ã¹ã·ãŒãã«ãŠã€ã«ã¹æ¶²ã2ml滎äžãã405nmã®å¯èŠå ã§å±èµ·ããŠåå¿ãããããšã§ãæ¶²äœäžã®SARS-CoV-2ã120åã§99.9ïŒ äžæŽ»åãããããšã確èªãããã
ããã«ããªãå è§ŠåªãäžæŽ»åã§ããã®ãã調ã¹ããããé»åé¡åŸ®é¡ãçšããè§£æãè¡ãããçµæãå è§Šåªåå¿ã«ãã£ãŠSARS-CoV-2ã®æ°ãæžå°ããããšãSARS-CoV-2ã®ãµã€ãºã倧ãããªãããšãSARS-CoV-2衚é¢ã®ã¹ãã€ã¯(S)ã¿ã³ãã¯è³ªã®æ°ãæžå°ããããšãªã©ãæãããšãªã£ãããã®é»åé¡åŸ®é¡ã«ãã芳å¯çµæã¯ãå è§Šåªåå¿ãSARS-CoV-2èªäœãžã®ãã¡ãŒãžãç¹ã«è質äºéèãžæå·ãäžããŠããããšãšãSã¿ã³ãã¯è³ªãåè§£ããŠããããšã瀺åããŠãããšããã
-

å è§Šåªã«ããSARS-CoV-2ã®äžæŽ»åã®ã¡ã«ããºã ãSARS-CoV-2ã¯Sã¿ã³ãã¯è³ªããã现èã®è¡šé¢ã«ååšããACE2(ã¢ã³ãžãªãã³ã·ã³å€æé µçŽ II)ãšçµåããããšã§ã现èå ã«äŸµå ¥ããã现èå ã«äŸµå ¥ããSARS-CoV-2ã¯RNAãæŸåºãããã现èã¯ç¥ããã«ãã®RNAã翻蚳ãããŠã€ã«ã¹ã¿ã³ãã¯è³ªãåæããŠããŸãããšã§ãæ°ããªSARS-CoV-2ã圢æãã现èå€ãžãšæŸåºããããšã§å¢æ®ããã(1)å è§Šåªã«ãããŠã€ã«ã¹ã®æå·ã¯ããŠã€ã«ã¹èªäœãç Žå£ããããšã«ãã£ãŠããã®ãŠã€ã«ã¹ã®ç掻ç°ãåããªãããã(2)å è§Šåªã«ãããŠã€ã«ã¹ã¿ã³ãã¯è³ªã®åè§£ãç¹ã«Sã¿ã³ãã¯è³ªã®åè§£ã¯ãŠã€ã«ã¹ã®çްèå ãžã®äŸµå ¥ãé»å®³ãããŠã€ã«ã¹ã®æææ§ãåªå€±ãããã(3)å è§Šåªã«ãããŠã€ã«ã¹RNAã®æå·ã¯ããŠã€ã«ã¹ã²ãã ããã®ãŠã€ã«ã¹ã¿ã³ãã¯è³ªãžã®ç¿»èš³ãé»å®³ãããŠã€ã«ã¹ãäžæŽ»åãã (åºæ:æ±äº¬å€§åŠWebãµã€ã)
å ããŠãæ¶²äœäžã§ã®120åéã®å è§Šåªåå¿ã«ãã£ãŠãSã¿ã³ãã¯è³ªããã³ãã¯ã¬ãªã·ã(N)ã¿ã³ãã¯è³ªãåè§£ãããããšãããŠã§ã¹ã¿ã³ããããã£ã³ã°æ³ã«ãã蚌æããããSã¿ã³ãã¯è³ªã¯ãããããã®çްèã«äŸµå ¥ããããã®éµã«äŸããããSARS-CoV-2ã«ãšã£ãŠã¯éèŠãªã¿ã³ãã¯è³ªã§ãNã¿ã³ãã¯è³ªãSARS-CoV-2ã®ç掻ç°ã«éèŠãªã¿ã³ãã¯è³ªã ããããã®ã¿ã³ãã¯è³ªãåè§£ããŠãããšããããšã¯ãå è§Šåªã«ããSARS-CoV-2ã®äžæŽ»åã¡ã«ããºã ã®1ã€ãšèãããããšããŠããã
åæ§ã«ãæ¶²äœäžã§ã®120åéã®å è§Šåªåå¿ã«ãã£ãŠãSARS-CoV-2ã®RNAãæå·ãåããããšãq-PCRæ³ã«ãã蚌æããããRNAãžã®æå·ã¯ããã现èäŸµå ¥åŸã®SARS-CoV-2ã®ç£çãé»å®³ããããšãããå è§Šåªã®SARS-CoV-2ã®äžæŽ»åã®éèŠãªã¡ã«ããºã ãšèãããããšããŠããã
å è§Šåªåå¿ã¯ã玫å€ç·ã®ããã«äººäœãžã®æå®³ãªäœçšããªãããšã¯ç¢ºèªæžã¿ã ããã®ããã人ã ãçæŽ»ããå±å 空éã«ãããŠå©çšã§ããSARS-CoV-2ã®ææãªã¹ã¯ã®æžå°ã«å¯äžãããšèãããããšããã
å ããŠãå è§Šåªã«ããé žååå¿ã«ãããŠã€ã«ã¹ã²ãã ããŠã€ã«ã¹ã¿ã³ãã¯è³ªããã³ãŠã€ã«ã¹ç²åãžã®æå·ãæ¹èµ·ãããããšãããSARS-CoV-2ã ãã§ãªããå è§Šåªã¯å¹ åºããŠã€ã«ã¹ãžã®å¿çšãæåŸ ããããšããã
ãŸãããŠã€ã«ã¹ã®çš®é¡ã«é¢ä¿ãªãå¿çšã§ãããšããããšã¯ãçŸåšè åšãšãªã£ãŠããSARS-CoV-2ã®å€ç°æ ªã«å¯ŸããŠãæå¹æ§ãæåŸ ããããšãããè¬å€ãã¯ã¯ãã³ã®å ŽåãããããäœçšããSARS-CoV-2ã®éšäœã«å€ç°ãå ããããšãã£ãŠãæšçãšãªããŠã€ã«ã¹ãæµææ§ãç²åŸã广ããªããªã£ãŠããŸãå¯èœæ§ãããã
ããã«å¯ŸããŠå è§Šåªåå¿ã§ã¯ãçºçããOHã©ãžã«ã«(掻æ§é žçŽ çš®)ãæŠåšãšããããšã§ãã¿ã³ãã¯è³ª(ææ©ç©)ã§ããã°äœã ãããšé žåããŠããŸããOHã©ãžã«ã«ã¯ããããç©è³ªãšåå¿ãããšèããããŠãããäžã§ãææ©ç©ãšã®åå¿ã¯ãããŸãããæçµçã«ã¯æ°ŽãCO2ã«ãŸã§åè§£ããŠããŸããšããããŠã€ã«ã¹ã¯çç©ã®ç¯çã«å«ãŸããŠããªãããææ©ç©ã§æ§æãããŠããç¹ã¯çç©ãšå ±éã§ãããã€ãŸããSã¿ã³ãã¯è³ªãNã¿ã³ãã¯è³ªããŠã€ã«ã¹ã¡ã³ãã©ã³(è質äºéè)ãRNAãªã©ãSARS-CoV-2ãæ§æãããããšãããããã¹ãŠãOHã©ãžã«ã«ã«ããåè§£ãé²ãããšãã§ããªããšããããšã§ããã
ãŠã€ã«ã¹ãå€ç°ããçµæãOHã©ãžã«ã«ãå¹ããªãäœè³ªãç²åŸããããšãæžå¿µããããããããªãããå€ç°ãããšã¯ãã£ãŠããSã¿ã³ãã¯è³ªãNã¿ã³ãã¯è³ªããŠã€ã«ã¹ã¡ã³ãã©ã³ãªã©ãSARS-CoV-2ã®äžéšã®åœ¢ç¶ãå€ãããªã©ããŠåŸæ¥ãšã¯ç°ãªãç¹åŸŽãåããããšã§ãããææ©ç©ã§æ§æãããŠããããšã¯å€ãããªããããã©ãã ãå€ç°ããããOHã©ãžã«ã«ã«å¯ŸããŠã¯ç¡é¢ä¿ã§ãããå è§Šåªã®æãŠã€ã«ã¹å¹æãæžå°ããããšã¯ãªããšããã
ãªããä»åã®å®éšã«ãããå è§Šåªæè¡ã§ç©ºæ°äžã«æµ®éããSARS-CoV-2ã®æææ§ãæ€åºéç以äžãŸã§æ¶å€±ãããããšãå®èšŒãããããšã¯ãWithã³ããã®ç€ŸäŒãå®çŸããããã®å®å¿ã§ããã¯ãªãŒã³ãªç©ºéæ§ç¯ãæåŸ ããããšç ç©¶ããŒã ã§ã¯èª¬æããããããšåæã«ãçŸåšè åšãšãªã£ãŠããå€ç°æ ªãæ°ããªç€ŸäŒçè åšãšãªãåŸãæªç¥ã®ãŠã€ã«ã¹ææçå æã®éãæããã®ã§ããããšãããä»åŸããŸããŸãå è§Šåªæè¡ã®ç€ŸäŒãžã®è²¢ç®åºŠãå¢ããšèãããããšããŠããã